Melanoma Drug Boosting Survival for Many, Study Shows

THURSDAY, May 19, 2016 — A new drug for advanced melanoma is dramatically shifting the odds in favor of patients, extending survival for many and even curing some.
Keytruda (pembrolizumab) helped keep four in 10 patients with advanced melanoma…
Source: Topamax